West Pharmaceutical Services (WST) Income Statement
West Pharmaceutical Services Income Statement
Last quarter (Q3 2026), West Pharmaceutical Services's total revenue was $874.50M, an increase of 8.73% from the same quarter last year. In Q3, West Pharmaceutical Services's net income was $214.00M. See West Pharmaceutical Services’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 3.07B | $ 2.89B | $ 2.95B | $ 2.89B | $ 2.83B | |
| $ 1.10B | $ 1.00B | $ 1.13B | $ 1.14B | $ 1.17B | |
| $ 485.90M | $ 407.60M | $ 421.80M | $ 375.40M | $ 414.70M | |
| Depreciation and Amortization | $ 171.40M | $ 155.40M | $ 137.30M | $ 120.60M | $ 122.30M |
| $ 770.60M | $ 743.80M | $ 844.10M | $ 808.10M | $ 879.70M | |
| $ 617.40M | $ 594.60M | $ 710.90M | $ 763.50M | $ 758.70M | |
| $ -2.10M | $ 5.60M | $ 4.80M | $ -62.90M | $ 10.30M | |
| $ 615.30M | $ 600.20M | $ 715.70M | $ 700.60M | $ 769.00M | |
| $ 493.70M | $ 492.70M | $ 593.40M | $ 585.90M | $ 661.80M | |
| Per Share Metrics | |||||
| Basic EPS | $ 6.83 | $ 6.75 | $ 7.99 | $ 7.88 | $ 8.90 |
| Diluted EPS | $ 6.80 | $ 6.69 | $ 7.88 | $ 7.73 | $ 8.67 |
| Weighted Average Shares Outstanding | 72.30M | 73.00M | 74.30M | 74.40M | 74.40M |
| Weighted Average Shares Outstanding (Diluted) | 72.70M | 73.70M | 75.30M | 75.80M | 76.30M |
Currency in USD